Taylor Jenkins Reid's ‘Atmosphere' Is Becoming a Movie! What We Know
Taylor Jenkins Reid fans, it's time to blast off, because the bestselling historical fiction author's newest book, Atmosphere, is officially being turned into a movie! It will be the seventh adaptation that Reid has worked on, but it will be the first one to be set in outer space. Below, we have compiled everything you need to know about the Atmosphere adaptation, including whether it connects to the author's other historical projects. Scroll on for more.
The Atmosphere adaptation was announced in May, a month before the book even hit shelves. It is expected to be produced by Laika Studios, and written and directed by Anna Boden and Ryan Fleck.
'We couldn't be more excited to team up with three boundary-pushing creative voices on this very special film,' said Matt Levin, Laika's President, Live Action Film & Series, per Deadline. 'From books like The Seven Husbands of Evelyn Hugo to Carrie Soto is Back, Taylor Jenkins Reid always captivates us with rich, emotionally complex characters and she is in peak form with Atmosphere. There are no better filmmakers to adapt Taylor's story for the screen than Ryan and Anna, who throughout their amazing careers have crafted deeply human stories set against canvases of stunning cinematic spectacle. We can't wait to see them bring Taylor's world of Atmosphere to life.'
Along with Atmosphere, Reid's other novels, The Seven Husbands of Evelyn Hugo, Malibu Rising and Carrie Soto Is Back are also in pre-production. She has had her bestselling historical fiction novel, Daisy Jones & The Six, adapted into a TV series, and her romance novel, One True Loves, adapted into a film, both of which were released in 2023.
Atmosphere is Reid's ninth novel, and it is her fifth one in the historical fiction realm. The plot follows Joan Goodwin, a professor of physics and astronomy, who makes history by becoming one of the first female scientists ever accepted into NASA's Space Shuttle training program. While there, she begins training alongside an extraordinary group of fellow candidates: Top Gun pilot John Griffin and scientist Hank Redmond, mission specialist Lydia Danes, Donna Fitzgerald and Vanessa Ford. Three years later, the group is still as strong as ever…until a 1984 rocket mission goes wrong, and Joan finds herself doing everything she can to bring her friends—and the person she loves— home before it's too late.
'Atmosphere pushed me to learn about astronomy, and to go outside and look up at the night sky,' Reid told People magazine in May. 'There is, for me, something really close to magical about standing in my backyard and looking up and seeing Orion's Belt …. It gives such a beautiful sense of how the world is turning in both a literal way and a metaphorical way.'
A common theme in Reid's historical fiction novels is that they all connect to each other in some way. Whether that's a recurring character—we are looking at you, Mick Riva—or newspaper clips, the author made sure to let readers know these books took place in the same universe.
The same cannot be said for Atmosphere, though. In this historical fiction, Joan and Vanessa are all alone, meaning that, sadly, in the film, we most likely won't see Daisy Jones or Evelyn Hugo pop up on our screens.
Since the Atmosphere adaptation news is relatively new, there is, unfortunately, no release date for the film yet. There is also no cast, but until there is, we will be sitting here on our spaceships anxiously waiting.
For more book news, keep scrolling!
V.E. Schwab on Why Her New Book Is an 'Unofficial Sequel' to 'Addie LaRue' (EXCLUSIVE)
'It's Kind of Hard To Believe': Abby Jimenez Opens up About Going From Baker to Bestseller (EXCLUSIVE)
10 Historical Fiction Books About Women in Wartime to Move and Inspire You
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South Wales Argus
8 minutes ago
- South Wales Argus
Rogerstone: Four-bed detached house in Alcan Grove for sale
The property, listed by Davis & Sons, boasts a large living room, study, utility room, conservatory, and a spacious kitchen diner. There is also an en-suite attached to the master bedroom, and another to the second bedroom. The property also features an entrance hall, utility room, and a downstairs WC. The conservatory (Image: Davis & Sons) The property has a large evergreen rear garden, a spacious lawn area, and a patio seating area. There is also a double driveway and garage to the front, providing ample off-street parking. The house is situated in a quiet residential area, close to local amenities, schools, and transport links. Rogerstone, a suburban village in Newport, blends historic charm with modern convenience. One of the bedrooms (Image: Davis & Sons) It offers well-regarded schools, green spaces like the Fourteen Locks Canal Centre, and regular rail links to Newport and Cardiff via Rogerstone station. With easy access to the M4, it is a popular choice for families and commuters seeking a strong community feel with excellent transport connections. The agency states: "This property is not to be missed." To arrange a viewing, contact the Newport head office or reach out via email.
Yahoo
8 minutes ago
- Yahoo
Alex Pereira: Focus on Magomed Ankalaev rematch, not heavyweight move
NEW YORK—Fans clamoring for Alex Pereira to move to heavyweight are going to have to wait a bit longer. Pereira dropped the UFC light heavyweight title to Magomed Ankalaev in the main event of UFC 313 in March. With the heavyweight division up in the air, Jon Jones saying multiple times he's not interested in fighting right now, and interim champ Tom Aspinall looking for an opponent, 'Poatan' would be a popular choice to flip one of the UFC's thinner divisions upside down. Advertisement That time is not now, however, as Pereira has his sights set on a fall return to avenge his loss to Ankalaev. 'Anywhere around the timeframe [of] September, October, November, for me it makes no difference, I want to fight,' Pereira told MMA Fighting at Fanatics Fest. 'My focus right now is fighting Ankalaev... get my belt back, and then we see what happens after.' Pereira has accomplished so much in so little time that the opportunity to win a third divisional title seems like a reasonable goal and request. Right now, Pereira hopes the heavyweight division can get moving again in an entertaining way, but he has his own boxes to check. Advertisement 'Let those guys kill each other in that weight class,' Pereira said. 'Right now I'm just focusing on light heavyweight.' More from
The Independent
8 minutes ago
- The Independent
Weight loss pill shows promise in new trial
A new weight loss medication, which can be offered by injection or tablet, can help patients lose a significant amount weight, studies suggest. An early study have found that people who received higher doses of amycretin as a weekly jab lost 24.3% of their body weight after 36 weeks of treatment. And initial trials assessing a tablet form of the drug also showed promising results, with patients taking daily tablets losing an average of 13.1% of their body weight after 12 weeks. Weight loss jabs have been hailed as transformative by NHS leaders. But injections come with additional work for over-stretched health services so tablet forms of medication may offer a new hope for the millions of people looking to lose weight. It has been estimated that around 1.5 million Britons are having weight loss jabs, which have been either prescribed through specialist weight loss services or private prescriptions. GPs will be able to dish out that jabs from next week. Amycretin, made by Novo Nordisk, helps to control blood sugar and appetite by targeting two specific receptors in the body – GLP-1 and the amylin receptor. An early trial in 125 adults testing weekly injections of amycretin, which has been published in The Lancet, found that those taking the highest dosage (60mg) lost 24.3% after 36 weeks of treatment. It also showed signs in improving blood sugar levels. Side effects included nausea and vomiting and were mostly mild to moderate and resolved by the end of treatment. 'These phase 1b/2a data support the potential of once-weekly subcutaneous amycretin as a therapeutic for people living with overweight or obesity,' the authors wrote. 'Amycretin appeared safe and tolerable, and there were significant reductions in body weight after 36 weeks of treatment.' The second early trial, published in the same journal, assessed amycretin in tablet form in 144 people over 12 weeks. There were mild to moderate side effects including loss of appetite, nausea and vomiting. Researchers found that people taking the highest dose of 100mg per day, lost 13.1% of their body weight over four months. The authors wrote: 'Amycretin effectively lowered body weight and improved metabolic and glycaemic parameters in people with overweight or obesity. 'Longer studies with more participants are warranted for evaluation of the safety and efficacy of amycretin in individuals living with obesity and type 2 diabetes, and to optimise the dosing regimen.' The studies were also presented at the American Diabetes Association's Scientific Sessions in Chicago, in the US. It comes as a separate study, which was published at the same meeting, examined the effects of weight loss jab Wegovy at higher doses. Researchers found that giving patients 7.2mg of Wegovy, also known as semaglutide, once a week led to an average weight loss of 20.7%, with a third of participants losing 25% or more of their body weight after 72 weeks.
